Related Experiment Video
Updated: Aug 13, 2026
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Direct determination of plasma endothelin-I by chemiluminescence enzyme immunoassay
1Pharmaceutical Research Laboratory, Hitachi Chemical Co., Ibaraki, Japan. HCN00974@niftyserve.or.jp
Insights
A new chemiluminescence immunoassay for plasma endothelin-1 (ET-1) offers high sensitivity without extraction. This reliable assay accurately detects ET-1, crucial for cardiovascular research.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Endothelin-1 (ET-1) is a potent vasoconstrictor with implications in cardiovascular diseases.
- Accurate quantification of plasma ET-1 is essential for clinical diagnosis and research.
- Existing ET-1 assays often require complex extraction steps, limiting their efficiency.
Purpose of the Study:
- To develop a highly sensitive and direct sandwich-type chemiluminescence enzyme immunoassay (CLEIA) for plasma ET-1.
- To eliminate the need for prior extraction steps in ET-1 quantification.
- To validate the assay's sensitivity, specificity, and reliability.
Main Methods:
- Development of a sandwich CLEIA utilizing two distinct polyclonal antibody populations.
- One antibody targets the C-terminus of ET-1; a Fab' fragment against the N-terminus, coupled with horseradish peroxidase (HRP), serves as the label.
- HRP activity was measured using an enhanced chemiluminescence reaction (luminol/hydrogen peroxide).
Main Results:
- The developed assay demonstrated high sensitivity, detecting as low as 0.5 ng/L (0.05 pg/well) of plasma ET-1.
- The assay exhibited no significant cross-reactivity with related peptides like endothelin-3 and big ET-1.
- Assay reliability was confirmed through comparison with an established extraction-based method and a commercial kit.
Conclusions:
- A novel, extraction-free CLEIA for plasma ET-1 has been successfully developed.
- This assay provides a sensitive, specific, and reliable method for ET-1 quantification.
- The simplified procedure offers a valuable tool for cardiovascular research and diagnostics.
Abstract:
A highly sensitive sandwich-type chemiluminescence enzyme immunoassay for plasma endothelin-I (ET-1), involving no extraction steps, has been developed. Two populations of polyclonal antibodies were used in the present study: One is specific to the C-terminus of the endothelin family of peptides; the other, a Fab' fragment against the N-terminal core region of ET-1, is coupled with horseradish peroxidase (HRP). Labeled HRP activity was measured by using an enhanced chemiluminescence reaction of luminol/hydrogen peroxide. The assay was sensitive enough to detect 0.5 ng/L (0.05 pg/well) of plasma ET-1 and had no significant cross-reactivities with other related peptides, including endothelin-3 and the endothelin precursor peptide, big ET-1. Reliability of the assay was confirmed by comparison with an extraction-based procedure and a commercial kit.
